Screener
Nuvation Bio NUVB Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of collaboration and license agreements revenue | 8,560 | 2,404 | 14,176 | 4,498 |
| Research and development | 30,661 | 27,362 | 65,708 | 51,963 |
| Selling, general and administrative | 42,591 | 38,484 | 80,900 | 73,877 |
| Total costs and expenses | 82,723 | 68,422 | 162,070 | 130,510 |
| Loss from operations | (51,036) | (63,589) | (47,155) | (122,593) |
| Other income (expense): | ||||
| Interest income | 4,596 | 4,780 | 9,704 | 10,101 |
| Interest expense | (6,759) | (421) | (13,467) | (475) |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's other operating expenses?
- Nuvation Bio (NUVB) reported other operating expenses of $82.72M in Q2 2026.
- How has Nuvation Bio's other operating expenses changed year-over-year?
- Nuvation Bio's other operating expenses increased by 20.9% year-over-year, from $68.42M to $82.72M.
- What is the long-term trend for Nuvation Bio's other operating expenses?
- Over 4 years (2021 to 2025), Nuvation Bio's other operating expenses has grown at a 31.7% compound annual growth rate (CAGR), from $93.32M to $280.64M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Nuvation Bio's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude